Skip to content

Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06038734
Enrollment
108
Registered
2023-09-15
Start date
2023-11-10
Completion date
2024-04-17
Last updated
2024-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed Gastric Emptying, Gastroparesis

Keywords

GLP-1 agonists, retained gastric contents, glucagon-like peptide receptor-1 agonists, perioperative

Brief summary

Given the increased prescription of GLP-1 agonists for both diabetes and obesity management and the implications of the proposed delayed gastric emptying in the setting of an anesthetic, it is critical to determine if patients taking GLP-1 agonists have an increased rate of delayed gastric emptying. The purpose of this prospective gastric ultrasound evaluation of pre-operative patients is to determine the incidence of a full stomach despite a standard pre-operative fasting period.

Interventions

DIAGNOSTIC_TESTgastric ultrasound

Utilize POC gastric ultrasound to identify the presence of retained gastric contents.

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* GLP-1 agonist use within previous 30 days * Appropriately fasted per standard guidelines

Exclusion criteria

* History of gastric surgery / gastric volume reduction * Critical illness * Inability to provide informed consent * \<18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Retained gastric contentsAt time of pre-operative assessmentPresence of retained gastric contents, either liquid or solid

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026